These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 10366113
1. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. McKown KM, Carbone LD, Kaplan SB, Aelion JA, Lohr KM, Cremer MA, Bustillo J, Gonzalez M, Kaeley G, Steere EL, Somes GW, Myers LK, Seyer JM, Kang AH, Postlethwaite AE. Arthritis Rheum; 1999 Jun; 42(6):1204-8. PubMed ID: 10366113 [Abstract] [Full Text] [Related]
2. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. Häuselmann HJ, Caravatti M, Seifert B, Wang K, Bruckner P, Stucki G, Michel BA. Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751 [Abstract] [Full Text] [Related]
7. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ. Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815 [Abstract] [Full Text] [Related]
8. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V. Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [Abstract] [Full Text] [Related]
10. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial. Furuzawa-Carballeda J, Cabral AR, Zapata-Zuñiga M, Alcocer-Varela J. J Rheumatol; 2003 Feb; 30(2):256-9. PubMed ID: 12563677 [Abstract] [Full Text] [Related]
11. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P. Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [Abstract] [Full Text] [Related]
12. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis. Miranda JM, Alvarez-Nemegyei J, Saavedra MA, Terán L, Galván-Villegas F, García-Figueroa J, Jara LJ, Barile L, GRECIA Group. Arch Med Res; 2004 Jan; 35(1):36-42. PubMed ID: 15036798 [Abstract] [Full Text] [Related]
13. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D. Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396 [Abstract] [Full Text] [Related]
14. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial. Lü LJ, Teng JL, Bao CD, Han XH, Sun LY, Xu JH, Li XF, Wu HX. Chin Med J (Engl); 2008 Apr 05; 121(7):615-9. PubMed ID: 18466681 [Abstract] [Full Text] [Related]
15. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study. Gibofsky A, Rodrigues J, Fiechtner J, Berger M, Pan S. Clin Ther; 2007 Jun 05; 29(6):1071-85. PubMed ID: 17692722 [Abstract] [Full Text] [Related]
16. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. Biegert C, Wagner I, Lüdtke R, Kötter I, Lohmüller C, Günaydin I, Taxis K, Heide L. J Rheumatol; 2004 Nov 05; 31(11):2121-30. PubMed ID: 15517622 [Abstract] [Full Text] [Related]
17. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. Abe T, Takeuchi T, Miyasaka N, Hashimoto H, Kondo H, Ichikawa Y, Nagaya I. J Rheumatol; 2006 Jan 05; 33(1):37-44. PubMed ID: 16395748 [Abstract] [Full Text] [Related]
18. Effects of clarithromycin in patients with active rheumatoid arthritis. Ogrendik M. Curr Med Res Opin; 2007 Mar 05; 23(3):515-22. PubMed ID: 17355733 [Abstract] [Full Text] [Related]
19. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW. Clin Ther; 2006 Dec 05; 28(12):2052-60. PubMed ID: 17296461 [Abstract] [Full Text] [Related]
20. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. van den Borne BE, Landewé RB, Goei The HS, Rietveld JH, Zwinderman AH, Bruyn GA, Breedveld FC, Dijkmans BA. J Rheumatol; 1998 Aug 05; 25(8):1493-8. PubMed ID: 9712089 [Abstract] [Full Text] [Related] Page: [Next] [New Search]